Fig. 5.
The influence of filler type on etodolac release from Precirol® ATO 5-containing lipid matrix tablet (L5) in Sorensen’s phosphate buffer (pH 7.4) at 37 ± 0.5°C (mean ± S.D., n = 3)
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.